Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FTKQF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,082.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price contract valued at $2,082.90 for the supply of Nexplanon 68 mg implants. The contract was awarded by the Defense Logistics Agency on August 27, 2025, with an ultimate completion date of September 18, 2025. No set-aside designation was utilized for this award. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities.
Nexplanon implants are contraceptive devices that represent one of many specialized pharmaceutical products within DMS Pharmaceutical Group's extensive federal procurement portfolio. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with DLA to deliver branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military health facilities nationwide. The firm fixed-price arrangement and compressed performance timeline reflect the delivery order mechanism's flexibility in fulfilling urgent or routine medical supply requirements across the Defense Department's healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FTKQF?
SPE2DB25FTKQF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FTKQF worth?
The government has obligated $2,083 on SPE2DB25FTKQF.
Is contract SPE2DB25FTKQF an order under another contract?
Yes. SPE2DB25FTKQF is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKQF competed?
The extent of competition for SPE2DB25FTKQF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award